LSR Life Sciences Research

Law office of Brodsky & Smith, LLC announces that a class action lawsuit has been filed in the Superior Court of New Jersey against Life Sciences Research, Inc. ("Life Sciences Research" or the "Company") (NYSE: LSR) and the Company's Board of Directors challenging the proposed acquisition of the Company by Lion Holdings, Inc. ("Lion Holdings"). Andrew Baker, CEO of Life Sciences Research, is the controlling member of Lion Holdings and currently owns more than 17% of the outstanding stock of Life Sciences Research.

Under the proposed agreement, Life Sciences Research shareholders will receive $8.50 in cash for each share they own. The deal is valued at approximately $113 million. Throughout 2008, Life Sciences Research traded at significantly above the offer price. As recently as October 2008 it was trading above $35.00 a share and was still trading above $10.00 a share in December 2008.

If you own shares of Life Sciences Research and wish to discuss the legal ramifications of the proposed acquisition by Lion Holdings, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Marc Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at clients@brodsky-smith.com, or by calling toll free 877-LEGAL-90.

Jason L. Brodsky, Esquire Marc Ackerman, Esquire Brodsky & Smith, LLC Email Contact 877-LEGAL-90